Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study

被引:34
作者
Cheng, Kunming [1 ]
Zhang, Huan [2 ,3 ]
Guo, Qiang [4 ,5 ]
Zhai, Pengfei [5 ,6 ]
Zhou, Yan [5 ,7 ,8 ]
Yang, Weiguang [5 ,7 ]
Wang, Yulin [5 ,7 ]
Lu, Yanqiu [1 ]
Shen, Zefeng [9 ]
Wu, Haiyang [5 ,7 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 2, Dept Intens Care Unit, Zhengzhou, Peoples R China
[2] Nantong Univ, Dept Neurosurg, Affiliated Hosp 2, Nantong, Peoples R China
[3] First Peoples Hosp Nantong City, Nantong, Peoples R China
[4] Tianjin Med Univ, Dept Orhopaed Surg, Baodi Clin Coll, Tianjin, Peoples R China
[5] Tianjin Med Univ, Dept Clin, Coll Neurol Neurosurg & Neurorehabil, Tianjin, Peoples R China
[6] Tianjin Huanhu Hosp, Dept NeuroSpine Surg, Tianjin, Peoples R China
[7] Tianjin Med Univ, Dept Grad Sch, Tianjin, Peoples R China
[8] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin, Peoples R China
[9] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Grad Sch, Guangzhou, Peoples R China
基金
英国科研创新办公室;
关键词
oncolytic virus; central nervous system; tumors; immunotherapy; bibliometric analysis; hotspots; VIRUS THERAPY; GLIOMA VIROTHERAPY; ANTITUMOR-ACTIVITY; GLIOBLASTOMA; ADENOVIRUS; CELLS; TRIAL; MUTANT; IMMUNOVIROTHERAPY; ERADICATION;
D O I
10.3389/fimmu.2022.975695
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundCentral nervous system tumor (CNST) is one of the most complicated and lethal forms of human tumors with very limited treatment options. In recent years, growing evidence indicates that oncolytic virotherapy (OVT) has emerged as a promising therapeutic strategy for CNSTs. And a considerable amount of literature on OVT-CNSTs has been published. However, there are still no studies summarizing the global research trends and hotspots of this field through a bibliometric approach. To fulfill this knowledge gap, bibliometric analysis was conducted based on all publications relating to OVT-CNSTs since 2000s. MethodsWe searched the Web of Science Core Collection for all relevant studies published between 2000 and 2022. Four different tools (online analysis platform, R-bibliometrix, CiteSpace and VOSviewer) were used to perform bibliometric analysis and network visualization, including annual publication output, active journals, contribution of countries, institutions, and authors, references, as well as keywords. ResultsA total of 473 articles and reviews were included. The annual number of publications on OVT-CNSTs showed a significant increasing trend. Molecular Therapy and Cancer Research were the most active and co-cited journals, respectively. In terms of contributions, there is no doubt that the United States occupied a leading position with the most publications (n=307, 64.9%) and the highest H-index (57). The institution and author that contributed the largest number of publications were Ohio State University and Chiocca EA, respectively. As can be seen from citation analysis, the current studies mainly focused on preclinical and phase I/II clinical results of various oncolytic virus for CNSTs treatment. Keywords co-occurrence and burst analysis revealed that the following research topics including immunotherapy, T-cells, tumor microenvironment, vaccine, blood-brain-barrier, checkpoint inhibitors, macrophage, stem cell, and recurrent glioblastoma have been research frontiers of this field and also have great potential to continue to be research hotspots in the future. ConclusionThere has been increasing attention on oncolytic viruses for use as CNSTs therapeutics. Oncolytic immunotherapy is a topic of great concern in this field. This bibliometric study provides a comprehensive analysis of the knowledge base, research hotspots, development perspective in the field of OVT-CNSTs, which could become an essential reference for scholars in this area.
引用
收藏
页数:20
相关论文
共 80 条
[61]   Intraarterial delivery of virotherapy for glioblastoma [J].
Srinivasan, Visish M. ;
Lang, Frederick F. ;
Kan, Peter .
NEUROSURGICAL FOCUS, 2021, 50 (02) :1-9
[62]   Oncolytic Viruses for Malignant Glioma: On the Verge of Success? [J].
Suryawanshi, Yogesh R. ;
Schulze, Autumn J. .
VIRUSES-BASEL, 2021, 13 (07)
[63]  
Synnestvedt Marie B, 2005, AMIA Annu Symp Proc, P724
[64]   Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo [J].
Tyler, M. A. ;
Ulasov, I. V. ;
Sonabend, A. M. ;
Nandi, S. ;
Han, Y. ;
Marler, S. ;
Roth, J. ;
Lesniak, M. S. .
GENE THERAPY, 2009, 16 (02) :262-278
[65]   Software survey: VOSviewer, a computer program for bibliometric mapping [J].
van Eck, Nees Jan ;
Waltman, Ludo .
SCIENTOMETRICS, 2010, 84 (02) :523-538
[66]   Oncolytic herpes simplex virus vectors for cancer virotherapy [J].
Varghese, S ;
Rabkin, SD .
CANCER GENE THERAPY, 2002, 9 (12) :967-978
[67]   Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma [J].
Vasileva, Natalia ;
Ageenko, Alisa ;
Dmitrieva, Maria ;
Nushtaeva, Anna ;
Mishinov, Sergey ;
Kochneva, Galina ;
Richter, Vladimir ;
Kuligina, Elena .
LIFE-BASEL, 2021, 11 (10)
[68]   Reovirus as an oncolytic agent against experimental human malignant gliomas [J].
Wilcox, ME ;
Yang, WQ ;
Senger, D ;
Rewcastle, NB ;
Morris, DG ;
Brasher, PMA ;
Shi, ZQ ;
Johnston, RN ;
Nishikawa, S ;
Lee, PWK ;
Forsyth, PA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (12) :903-912
[69]   Oncolytic Virus Therapy for Glioblastoma Multiforme Concepts and Candidates [J].
Wollmann, Guido ;
Ozduman, Koray ;
van den Pol, Anthony N. .
CANCER JOURNAL, 2012, 18 (01) :69-81
[70]   CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells [J].
Wu, Hailong ;
Zhou, Yan ;
Wu, Haiyang ;
Xu, Lixia ;
Yan, Yan ;
Tong, Xiaoguang ;
Yan, Hua .
FRONTIERS IN GENETICS, 2021, 12